Chorea Market Research Information: by Type (Huntington’s disease, Sydenham’s chorea, Drug-induced chorea), Treatment (Medical Care, Surgical Care), Distribution Channel (Hospitals, Diagnostic Centers, Drug Stores, Pharmacies) – forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Chorea Market, by Type

6.1 Introduction

6.2 Huntington’s Disease

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Rheumatic (Sydenham’s chorea)

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Drug-Induced Chorea

6.4.1 Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Chorea Market, by Treatment

7.1 Introduction

7.2 Medical Care

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Surgical Care

7.3.1 Market Estimates & Forecast, 2020-2027

Chapter 8. Global Chorea Market, by Distribution Channel

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Clinics

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Diagnostic Centers

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Drug Stores

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Pharmacies

8.6.1 Market Estimates & Forecast, 2020-2027

8.7 Others

8.7.1 Market Estimates & Forecast, 2020-2027

Chapter 9. Global Chorea Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Teva Pharmaceutical Industries Ltd.

11.1.1 Company Overview

11.1.2 Type of Causative Agents Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Valeant

11.2.1 Company Overview

11.2.2 Type of Causative Agents Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Medtronic

11.3.1 Company Overview

11.3.2 Type of Causative Agents Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Alnylam Pharmaceuticals, Inc.

11.4.1 Company Overview

11.4.2 Type of Causative Agents/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Cyberonics, Inc.

11.5.1 Company Overview

11.5.2 Type of Causative Agents Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 AmpliPhi Biosciences Corp

11.6.1 Company Overview

11.6.2 Type of Causative Agents Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 CEREGENE INC.

11.7.1 Overview

11.7.2 Type of Causative Agents Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Chorea Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Chorea Industry Synopsis, 2020-2027

Table 2 Chorea Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Chorea Market by Region, 2020-2027, (USD Million)

Table 4 Chorea Market by Type, 2020-2027, (USD Million)

Table 5 Chorea Market by Treatment, 2020-2027, (USD Million)

Table 6 Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 7 North America Chorea Market by Type, 2020-2027, (USD Million)

Table 8 North America Chorea Market by Treatment, 2020-2027, (USD Million)

Table 9 North America Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 10 US Chorea Market by Type, 2020-2027, (USD Million)

Table 11 US Chorea Market by Treatment, 2020-2027, (USD Million)

Table 12 US Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 13 Canada Chorea market by Type, 2020-2027, (USD Million)

Table 14 Canada Chorea Market by Treatment, 2020-2027, (USD Million)

Table 15 Canada Chorea market by Distribution Channels, 2020-2027, (USD Million)

Table 16 South America Chorea Market by Type, 2020-2027, (USD Million)

Table 17 South America Chorea Market by Treatment, 2020-2027, (USD Million)

Table 18 South America Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 19 Europe Chorea Market by Type, 2020-2027, (USD Million)

Table 20 Europe Chorea Market by Treatment, 2020-2027, (USD Million)

Table 21 Europe Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 22 Western Europe Chorea Market by Type, 2020-2027, (USD Million)

Table 23 Western Europe Chorea Market by Treatment, 2020-2027, (USD Million)

Table 24 Western Europe Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 25 Eastern Europe Chorea market by Type, 2020-2027, (USD Million)

Table 26 Eastern Europe Chorea Market by Treatment, 2020-2027, (USD Million)

Table 27 Eastern Europe Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 28 Asia Pacific Chorea Market by Type, 2020-2027, (USD Million)

Table 29 Asia Pacific Chorea Market by Treatment, 2020-2027, (USD Million)

Table 30 Asia Pacific Chorea market by Distribution Channels, 2020-2027, (USD Million)

Table 31 Middle East & Africa Chorea Market by Type, 2020-2027, (USD Million)

Table 32 Middle East & Africa Chorea Market by Treatment, 2020-2027, (USD Million)

Table 33 Middle East & Africa Chorea market by Distribution Channels, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Chorea Market

Figure 3 Segmentation Market Dynamics for Chorea Market

Figure 4 Global Chorea market Share, by Type 2027

Figure 5 Global Chorea market Share, by Treatment 2027

Figure 6 Global Chorea market Share, by Distribution Channels, 2027

Figure 7 Global Chorea market Share, by Region, 2027

Figure 8 North America Chorea market Share, by Country, 2027

Figure 9 Europe Chorea market Share, by Country, 2027

Figure 10 Asia Pacific Chorea market Share, by Country, 2027

Figure 11 Middle East & Africa Chorea market Share, by Country, 2027

Figure 12 Global Chorea market: Company Share Analysis, 2027 (%)

Figure 13 Teva Pharmaceutical Industries Ltd.: Key Financials

Figure 14 Teva Pharmaceutical Industries Ltd. Segmental Revenue

Figure 15 Teva Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 16 Valeant: Key Financials

Figure 17 Valeant: Segmental Revenue

Figure 18 Valeant: Geographical Revenue

Figure 19 Medtronic: Key Financials

Figure 20 Medtronic: Segmental Revenue

Figure 21 Medtronic: Geographical Revenue

Figure 22 Alnylam Pharmaceuticals, Inc.: Key Financials

Figure 23 Alnylam Pharmaceuticals, Inc.: Segmental Revenue

Figure 24 Alnylam Pharmaceuticals, Inc.: Geographical Revenue

Figure 25 Cyberonics, Inc.: Key Financials

Figure 26 Cyberonics, Inc.: Segmental Revenue

Figure 27 Cyberonics, Inc. Geographical Revenue

Figure 28 AmpliPhi Biosciences Corp: Key Financials

Figure 29 AmpliPhi Biosciences Corp: Segmental Revenue

Figure 30 AmpliPhi Biosciences Corp: Geographical Revenue

Figure 31 CEREGENE INC.: Key Financials

Figure 32 CEREGENE INC.: Segmental Revenue

Figure 33 CEREGENE INC.: Geographical Revenue